Skip to content
No picture yet

Sandoz Repaglinide 0.5 mg – DIN 02357453

Sandoz Repaglinide is Repaglinide 0.5 mg (tablet), sold in Canada. It is used for type 2 diabetes. It is supplied by Sandoz Canada Incorporated. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.

Sold in Canada

Repaglinide 0.5 mg

Brand
Sandoz Repaglinide
Strength
0.5 mg
Used for
Type 2 diabetes
Form
Tablet
Manufacturer
Sandoz Canada Incorporated
Drug class
Diabetes medicine
Sold in
Canada
DIN
02357453

Source: Health Canada's Drug Product Database. Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Repaglinide pills and guides

What is Repaglinide used for?

Repaglinide is used for type 2 diabetes.

Medicine type
Diabetes medicine
Official uses from the US prescribing label

Repaglinide tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Limitation of Use: Repaglinide tablets should not be used in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis.

From the FDA-approved label on DailyMed (published Nov 17, 2025).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your medicine? Check the box

  • The box or bottle shows DIN 02357453.
  • It names Sandoz Repaglinide, Repaglinide 0.5 mg.
  • A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.

Sold in Canada as Sandoz Repaglinide by Sandoz Canada Incorporated.

In Canada: prescription only.

Ingredients

Active: Repaglinide

Other Repaglinide pills